Literature DB >> 23021099

Predictors of outcome after short-term stabilization with buprenorphine.

Maureen Hillhouse1, Catherine P Canamar, Walter Ling.   

Abstract

Using buprenorphine as a medication to treat opioid dependence is becoming more prevalent as illicit opiate use increases. Identifying the characteristics of opiate dependent individuals best suited to benefit from buprenorphine would improve guidelines for its administration. This study evaluates baseline and treatment participation variables for predicting positive response to short-term stabilization with buprenorphine. Data include demographic, drug use, and other variables collected from participants undergoing stabilization over a 4-week period before being tapered off buprenorphine in a short-term detoxification process. Outcome variables include opioid use and retention. Logistic regression results indicate several characteristics associated with opioid use at the end of the stabilization period. These include being older, having no criminal history, and less opiate use. Criminal activity and opioid use in the last 30 days were significantly associated with shorter treatment stays. The benefits of identifying individual characteristics that may predict treatment response are discussed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021099      PMCID: PMC3545105          DOI: 10.1016/j.jsat.2012.08.016

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  29 in total

1.  Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet.

Authors:  L Amass; J B Kamien; S K Mikulich
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

2.  Drug abuse treatment retention and process effects on follow-up outcomes.

Authors:  D D Simpson; G W Joe; G A Rowan-Szal
Journal:  Drug Alcohol Depend       Date:  1997-09-25       Impact factor: 4.492

3.  Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction.

Authors:  A R Childress; A T McLellan; C P O'Brien
Journal:  Br J Addict       Date:  1986-10

4.  New data from the Addiction Severity Index. Reliability and validity in three centers.

Authors:  A T McLellan; L Luborsky; J Cacciola; J Griffith; F Evans; H L Barr; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1985-07       Impact factor: 2.254

5.  Pre- and in-treatment predictors of retention in methadone treatment using survival analysis.

Authors:  S Magura; P C Nwakeze; S Y Demsky
Journal:  Addiction       Date:  1998-01       Impact factor: 6.526

6.  A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.

Authors:  W K Bickel; M L Stitzer; G E Bigelow; I A Liebson; D R Jasinski; R E Johnson
Journal:  Clin Pharmacol Ther       Date:  1988-01       Impact factor: 6.875

7.  Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.

Authors:  G Gerra; F Borella; A Zaimovic; G Moi; M Bussandri; C Bubici; S Bertacca
Journal:  Drug Alcohol Depend       Date:  2004-07-15       Impact factor: 4.492

Review 8.  The Clinical Opiate Withdrawal Scale (COWS).

Authors:  Donald R Wesson; Walter Ling
Journal:  J Psychoactive Drugs       Date:  2003 Apr-Jun

9.  Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.

Authors:  W K Bickel; M L Stitzer; G E Bigelow; I A Liebson; D R Jasinski; R E Johnson
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

10.  Reactivity to alcohol-related cues: physiological and subjective responses in alcoholics and nonproblem drinkers.

Authors:  R F Kaplan; N L Cooney; L H Baker; R A Gillespie; R E Meyer; O F Pomerleau
Journal:  J Stud Alcohol       Date:  1985-07
View more
  15 in total

1.  Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.

Authors:  Phoebe A Cushman; Jane M Liebschutz; Bradley J Anderson; Merredith R Moreau; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2016-06-11

2.  Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.

Authors:  Babak Tofighi; Arthur Robin Williams; Chemi Chemi; Selena Suhail-Sindhu; Vicky Dickson; Joshua D Lee
Journal:  Subst Use Misuse       Date:  2019-08-20       Impact factor: 2.164

3.  Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder.

Authors:  Zev Schuman-Olivier; M Claire Greene; Brandon G Bergman; John F Kelly
Journal:  Drug Alcohol Depend       Date:  2014-09-18       Impact factor: 4.492

4.  Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.

Authors:  Kostyantyn Dumchev; Sergii Dvoryak; Olena Chernova; Olga Morozova; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2017-08-08

5.  Using behavioral economics to predict opioid use during prescription opioid dependence treatment.

Authors:  Matthew J Worley; Steven J Shoptaw; Warren K Bickel; Walter Ling
Journal:  Drug Alcohol Depend       Date:  2014-12-30       Impact factor: 4.492

6.  Opioid agonist therapy.

Authors:  Kathleen Broad; Hector Ahmed Colon-Rivera; Lamia Haque
Journal:  Can Fam Physician       Date:  2017-07       Impact factor: 3.275

Review 7.  Buprenorphine for managing opioid withdrawal.

Authors:  Linda Gowing; Robert Ali; Jason M White; Dalitso Mbewe
Journal:  Cochrane Database Syst Rev       Date:  2017-02-21

8.  Defining and Predicting Opioid and Cocaine Treatment Response.

Authors:  Robert A Gardner; David H Epstein; Kenzie L Preston; Karran A Phillips
Journal:  Subst Use Misuse       Date:  2019-07-18       Impact factor: 2.164

9.  Progression to regular heroin use: examination of patterns, predictors, and consequences.

Authors:  Eric A Woodcock; Leslie H Lundahl; Jonathan J K Stoltman; Mark K Greenwald
Journal:  Addict Behav       Date:  2015-02-26       Impact factor: 3.913

10.  Predictors of early dropout in outpatient buprenorphine/naloxone treatment.

Authors:  David E Marcovitz; R Kathryn McHugh; Julie Volpe; Victoria Votaw; Hilary S Connery
Journal:  Am J Addict       Date:  2016-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.